HIV-TAT enhances the transdermal delivery of NSAID drugs from liquid crystalline mesophases

Journal of Physical Chemistry B

Volumn 118, Issue 23, 2014, Pages 6277-6287

  Cohen Avrahami, Marganit ^a   Shames, Alexander I ^b   Ottaviani, M Francesca ^c   Aserin, Abraham ^a   Garti, Nissim ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c UNIVERSITY OF URBINO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; DRUG INTERACTIONS; SODIUM;

ANTI-INFLAMMATORIES; CELL-PENETRATING PEPTIDE; CHEMICAL COMPOSITIONS; GLYCEROL MONOOLEATE; LIQUID CRYSTALLINE MESOPHASES; SECONDARY STRUCTURES; SKIN PENETRATION ENHANCERS; TRANSDERMAL DELIVERY;

LAMELLAR STRUCTURES;

20,22-DIHYDRODIGOXIN-21,23-DIOL; ACYLGLYCEROL; CELECOXIB; DICLOFENAC; DIGOXIN; DRUG CARRIER; GLYCEROL OLEATE; NONSTEROID ANTIINFLAMMATORY AGENT; TRANSACTIVATOR PROTEIN; WATER;

ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; CUTANEOUS DRUG ADMINISTRATION; DIFFUSION; DRUG EFFECTS; LIQUID CRYSTAL; METABOLISM; PERMEABILITY; PIG; PROTEIN SECONDARY STRUCTURE; SKIN; VISCOSITY;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELECOXIB; DICLOFENAC; DIFFUSION; DIGOXIN; DRUG CARRIERS; GLYCERIDES; LIQUID CRYSTALS; PERMEABILITY; PROTEIN STRUCTURE, SECONDARY; SKIN; SUS SCROFA; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; VISCOSITY; WATER;

EID: 84902438665     PISSN: 15206106     EISSN: 15205207     Source Type: Journal    
DOI: 10.1021/jp412739p     Document Type: Article

References (64)

1. Engblom, J. Bicontinuous Cubic Phase: A Model for Investigating the Effects on a Lipid Bilayer due to a Foreign Substance Chem. Phys. Lipids 1996, 84, 155-164
2. Nguyen, T. H.; Hanley, T.; Porter, C. J. H.; Boyd, B. J. Nanostructured Liquid Crystalline Particles Provide Long Duration Sustained-Release Effect for a Poorly Water Soluble Drug After Oral Administration J. Controlled Release 2011, 153, 180-186
3. Tarafdar, P. K.; Reddy, S. T.; Swamy, M. J. Effect of Hofmeister Series Anions on the Thermotropic Phase Behavior of Bioactive O-Acylcholines J. Phys. Chem. B 2013, 117, 9900-9909
4. Helledi, L. S.; Schubert, L. Release Kinetics of Acyclovir from a Suspension of Acyclovir Incorporated in a Cubic Phase Delivery System Drug Dev. Ind. Pharm. 2001, 27, 1073-1081
5. Lee, K. W. Y.; Nguyen, T. H.; Hanley, T.; Boyd, B. J. Nanostructure of Liquid Crystalline Matrix Determines In Vitro Sustained Release and In Vivo Oral Absorption Kinetics for Hydrophilic Model Drugs Int. J. Pharm. 2009, 365, 190-199
6. Bitan-Cherbakovsky, L.; Libster, D.; Aserin, A.; Garti, N. Complex Dendrimer-Lyotropic Liquid Crystalline Systems: Structural Behavior and Interactions J. Phys. Chem. B 2011, 115, 11984-11992
7. Nunes, C.; Brezesinski, G.; Lima, J.; Reis, S.; Lucio, M. Synchrotron SAXS and WAXS Study of the Interactions of NSAIDs with Lipid Membranes J. Phys. Chem. B 2011, 115, 8024-8032
8. Efrat, R.; Shalev, D. E.; Hoffman, R. E.; Aserin, A.; Garti, N. Effect of Sodium Diclofenac Loads on Mesophase Components and Structure Langmuir 2008, 24, 7590-7595
9. Amar-Yuli, I.; Aserin, A.; Garti, N. Solubilization of Nutraceuticals into Reverse Hexagonal Mesophases J. Phys. Chem. B 2008, 112, 10171-10180
10. Achrai, B.; Libster, D.; Aserin, A.; Garti, N. Solubilization of Gabapentin into H-II Mesophases J. Phys. Chem. B 2011, 115, 825-835
11. Amar-Yuli, I.; Wachtel, E.; Shalev, D. E.; Aserin, A.; Garti, N. Low Viscosity Reversed Hexagonal Mesophases Induced by Hydrophilic Additives J. Phys. Chem. B 2008, 112, 3971-3982
12. Hawkey, C. J. COX-1 and COX-2 Inhibitors Best Pract. Res., Clin. Gastroenterol. 2001, 15, 801-820
13. Pereira-Leite, C.; Nunes, C.; Lima, J.; Reis, S.; Lucio, M. Interaction of Celecoxib with Membranes: The Role of Membrane Biophysics on its Therapeutic and Toxic Effects J. Phys. Chem. B 2012, 116, 13608-13617
14. Hirano, A.; Kameda, T.; Arakawa, T.; Shiraki, K. Arginine-Assisted Solubilization System for Drug Substances: Solubility Experiment and Simulation J. Phys. Chem. B 2010, 114, 13455-13462
15. Shakeel, F.; Baboota, S.; Ahuja, A.; Ali, J.; Shafiq, S. Skin Permeation Mechanism and Bioavailability Enhancement of Celecoxib from Transdermally Applied Nanoemulsion J. Nanobiotechnol. 2008, 6, 8-18
16. Singh, G.; Fort, J. G.; Goldstein, J. L.; Levy, R. A.; Hanrahan, P. S.; Bello, A. E.; Andrade-Ortega, L.; Wallemark, C.; Agrawal, N. M.; Eisen, G. M. G. Celecoxib Versus Naproxen and Diclofenac in Osteoarthritis Patients: SUCCESS-I Study Am. J. Med. 2006, 119, 255-266
17. Yariv, D.; Efrat, R.; Libster, D.; Aserin, A.; Garti, N. In Vitro Permeation of Diclofenac Salts from Lyotropic Liquid Crystalline Systems Colloids Surf., B 2010, 78, 185-192
18. Giri, A.; Bhowmick, M.; Pal, S.; Bandyopadhyaya, A. Polymer Hydrogel from Carboxymethyl Guar Gum and Carbon Nanotube for Sustained Trans-Dermal Release of Diclofenac Sodium Int. J. Biol. Macromol. 2011, 49, 885-893
19. Cohen-Avrahami, M.; Shames, A. I.; Ottaviani, M. F.; Aserin, A.; Garti, N. On the Correlation Between the Structure of Lyotropic Carriers and the Delivery Profiles of two Common NSAIDs. Colloids Surf. B, DOI: 10.1016/j.colsurfb.2014.04.026.
20. Frankel, A. D.; Pabo, C. O. Cellular Uptake of the TAT Protein from Human Immunodeficiency Virus Cell 1988, 55, 1189-1193
21. Heitz, F.; Morris, M. C.; Divita, G. Twenty Years of Cell-Penetrating Peptides: from Molecular Mechanisms to Therapeutics Br. J. Pharmacol. 2009, 157, 195-206
22. Bahnsen, J. S.; Franzyk, H.; Sandberg-Schaal, A.; Nielsen, H. M. Antimicrobial and Cell-Penetrating Properties of Penetratin Analogs: Effect of Sequence and Secondary Structure Biochim. Biophys. Acta, Biomembr. 2013, 1828, 223-232
23. Futaki, S.; Goto, S.; Suzuki, T.; Nakase, I.; Sugiura, Y. Structural Variety of Membrane Permeable Peptides Curr. Protein Pept. Sci. 2003, 4, 87-96
24. Kubiak-Ossowska, K.; Burley, G.; Patwardhan, S. V.; Mulheran, P. A. Spontaneous Membrane-Translocating Peptide Adsorption at Silica Surfaces: A Molecular Dynamics Study J. Phys. Chem. B 2013, 117, 14666-14675
25. Futaki, S. Arginine-Rich Peptides: Potential for Intracellular Delivery of Macromolecules and the Mystery of the Translocation Mechanisms Int. J. Pharm. 2002, 245, 1-7
26. Boudier, C.; Storchak, R.; Sharma, K. K.; Didier, P.; Follenius-Wund, A.; Muller, S.; Darlix, J. L.; Mely, Y. The Mechanism of HIV-1 Tat-Directed Nucleic Acid Annealing Supports its Role in Reverse Transcription J. Mol. Biol. 2010, 400, 487-501
27. Vitagliano, L.; Fiume, G.; Scognamiglio, P. L.; Doti, N.; Cannavo, R.; Puca, A.; Pedone, C.; Scala, G.; Quinto, I.; Marasco, D. Structural and Functional Insights into I kappa B-alpha/HIV-1 Tat Interaction Biochimie 2011, 93, 1592-1600
28. Rao, G. S.; Siddiqui, M. I.; Arora, S. Molecular Modeling of the HIV-1 TAT Protein-TAR RNA Complex and the Design of an Inhibitor of the Tat/TAR RNA Interaction J. Biomol. Struct. Dyn. 2000, 65-74
29. Devadas, K.; Boykins, R. A.; Hardegen, N. J.; Philp, D.; Kleinman, H. K.; Osa, E. O.; Wang, J.; Clouse, K. A.; Wahl, L. M.; Hewlett, I. K.; Rappaport, J.; Yamada, K. M.; Dhawan, S. S. Selective Side-Chain Modification of Cysteine and Arginine Residues Blocks Pathogenic Activity of HIV-1-Tat Functional Peptides Peptides 2006, 27, 611-621
30. Katayama, S.; Nakase, I.; Yano, Y.; Murayama, T.; Nakata, Y.; Matsuzaki, K.; Futaki, S. Effects of Pyrenebutyrate on the Translocation of Arginine-Rich Cell-Penetrating Peptides Through Artificial Membranes: Recruiting Peptides to the Membranes, Dissipating Liquid-Ordered Phases, and Inducing Curvature Biochim. Biophys. Acta, Biomembr. 2013, 1828, 2134-2142
31. Meade, B. R.; Dowdy, S. F. Exogenous siRNA Delivery Using Peptide Transduction Domains/Cell Penetrating Peptides Adv. Drug Delivery Rev. 2007, 59, 134-140
32. Kawamura, K. S.; Sung, M.; Bolewska-Pedyczak, E.; Gariepy, J. Probing the Impact of Valency on the Routing of Arginine-Rich Peptides into Eukaryotic Cells Biochemistry 2006, 45, 1116-1127
33. Wender, P. A.; Mitchell, D. J.; Pattabiraman, K.; Pelkey, E. T.; Steinman, L.; Rothbard, J. B. The Design, Synthesis, and Evaluation of Molecules that Enable or Enhance Cellular Uptake: Peptoid Molecular Transporters Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 13003-13008
34. Vives, E. Cellular Uptake of the Tat Peptide: an Endocytosis Mechanism Following Ionic Interactions J. Mol. Recognit. 2003, 16, 265-271
35. Wu, Z.; Cui, Q.; Yethiraj, A. Why Do Arginine and Lysine Organize Lipids Differently? Insights from Coarse-Grained and Atomistic Simulations J. Phys. Chem. B 2013, 117, 12145-12156
36. Hu, Y.; Ou, S. C.; Patel, S. Free Energetics of Arginine Permeation into Model DMPC Lipid Bilayers: Coupling of Effective Counterion Concentration and Lateral Bilayer Dimensions J. Phys. Chem. B 2013, 117, 11641-11653
37. Manosroi, J.; Lohcharoenkal, W.; Gotz, F.; Werner, R. G.; Manosroi, W.; Manosroi, A. Transdermal Absorption and Stability Enhancement of Salmon Calcitonin by TAT Peptide Drug Dev. Ind. Pharm. 2013, 39, 520-525
38. Shah, P. P.; Desai, P. R.; Channer, D.; Singh, M. Enhanced Skin Permeation Using Polyarginine Modified Nanostructured Lipid Carriers J. Controlled Release 2012, 161, 735-745
39. Libster, D.; Aserin, A.; Yariv, D.; Shoham, G.; Garti, N. Concentration- and Temperature-Induced Effects of Incorporated Desmopressin on the Properties of Reverse Hexagonal Mesophase J. Phys. Chem. B 2009, 113, 6336-6346
40. Sintov, A. C.; Botner, S. Transdermal Drug Delivery Using Microemulsion and Aqueous Systems: Influence of Skin Storage Conditions on the in vitro Permeability of Diclofenac from Aqueous Vehicle Systems Int. J. Pharm. 2006, 311, 55-62
41. Cohen-Avrahami, M.; Aserin, A.; Garti, N. H-II Mesophase and Peptide Cell-Penetrating Enhancers for Improved Transdermal Delivery of Sodium Diclofenac Colloids Surf., B 2010, 77, 131-138
42. Mason, P. E.; Neilson, G. W.; Dempsey, C. E.; Barnes, A. C.; Cruickshank, J. M. The Hydration Structure of Guanidinium and Thiocyanate ions: Implications for Protein Stability in Aqueous Solution Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 4557-4561
43. Libster, D.; Ben Ishai, P.; Aserin, A.; Shoham, G.; Garti, N. Molecular Interactions in Reverse Hexagonal Mesophase in the Presence of Cyclosporin A Int. J. Pharm. 2009, 367, 115-126
44. Cohen-Avrahami, M.; Libster, D.; Aserin, A.; Garti, N. Sodium Diclofenac and Cell-Penetrating Peptides Embedded in H-II Mesophases: Physical Characterization and Delivery J. Phys. Chem. B 2011, 115, 10189-10197
45. Senatra, D.; Gabrielli, G.; Caminati, G.; Zhou, Z. Conformational-Changes at the Microemulsion Water Oil Interface and their Influence on the Systems Dielectric Temperature Behavior IEEE Trans. Electr. Insul. 1988, 23, 579-589
46. Senatra, D.; Lendinara, L.; Giri, M. G. W/O Microemulsions as Model Systems for the Study of Water Confined in Microenvironments: Low-Resolution Proton Magnetic Resonance Relaxation Analysis Prog. Colloid Polym. Sci. 1991, 84, 122-128
47. Senatra, D.; Lendinara, L.; Giri, M. G. Different Degrees of Hydration in Water Oil Microemulsions by Low-Resolution H-1 Magnetic-Relaxation Analysis Can. J. Phys. 1990, 68, 1041-1048
48. Ezrahi, S.; Nir, I.; Aserin, A.; Kozlovich, N.; Feldman, Y.; Garti, N. Dielectric and Calorimetric Characteristics of Bound and Free Water in Surfactant-Based Systems J. Dispersion Sci. Technol. 2002, 23, 351-378
49. Garti, N.; Aserin, A.; Tiunova, I.; Fanun, M. A DSC Study of Water Behavior in Water-in-Oil Microemulsions Stabilized by Sucrose Esters and Butanol Colloids Surf., A 2000, 170, 1-18
50. Yaghmur, A.; Aserin, A.; Tiunova, I.; Garti, N. Sub-Zero Temperature Behaviour of Non-Ionic Microemulsions in the Presence of Propylene Glycol by DSC J. Therm. Anal. Calorim. 2002, 69, 163-177
51. Zhang, J.; Yan, Y. B. Probing Conformational Changes of Proteins by Quantitative Second-Derivative Infrared Spectroscopy Anal. Biochem. 2005, 340, 89-98
52. Vass, E.; Hollosi, M.; Besson, F.; Buchet, R. Vibrational Spectroscopic Detection of beta- and gamma-Turns in Synthetic and Natural Peptides and Proteins Chem. Rev. 2003, 103, 1917-1954
53. Kong, J.; Yu, S. Fourier Transform Infrared Spectroscopic Analysis of Protein Secondary Structures Acta Biochim. Biophys. Sin. 2007, 39, 549-559
54. Wang, Y. Q.; Boysen, R. I.; Wood, B. R.; Kansiz, M.; McNaughton, D.; Hearn, M. T. W. Determination of the Secondary Structure of Proteins in Different Environments by FTIR-ATR Spectroscopy and PLS Regression Biopolymers 2008, 89, 895-905
55. Krimm, S.; Bandekar, J. Vibrational Spectroscopy and Conformation of Peptides, Polypeptides, and Proteins Adv. Protein Chem. 1986, 38, 181-364
56. Shojania, S.; O'Neil, J. D. Intrinsic Disorder and Function of the HIV-1 Tat Protein Protein Pept. Lett. 2010, 17, 999-1011
57. Gabizon, R.; Mor, M.; Rosenberg, M. M.; Britan, L.; Hayouka, Z.; Kotler, M.; Shalev, D. E.; Friedler, A. Using Peptides to Study the Interaction Between the p53 Tetramerization Domain and HIV-1 Tat Biopolymers 2008, 90, 105-116
58. Su, Y. C.; Waring, A. J.; Ruchala, P.; Hong, M. Membrane-Bound Dynamic Structure of an Arginine-Rich Cell-Penetrating Peptide, the Protein Transduction Domain of HIV TAT, from Solid-State NMR Biochemistry 2010, 49, 6009-6020
59. Li, L. B.; Vorobyov, I.; Allen, T. W. The Different Interactions of Lysine and Arginine Side Chains with Lipid Membranes J. Phys. Chem. B 2013, 117, 11906-11920
60. Herce, H. D.; Garcia, A. E. Molecular Dynamics Simulations Suggest a Mechanism for Translocation of the HIV-1 TAT Peptide Across Lipid Membranes Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 20805-20810
61. Bitan-Cherbakovsky, L.; Libster, D.; Ottaviani, M. F.; Aserin, A.; Garti, N. Structural Behavior and Interactions of Dendrimer within Lyotropic Liquid Crystals, Monitored by EPR Spectroscopy and Rheology J. Phys. Chem. B 2012, 116, 2420-2429
62. Budil, D. E.; Lee, S.; Saxena, S.; Freed, J. H. Nonlinear-Least-Squares Analysis of Slow-Motion EPR Spectra in One and Two Dimensions Using a Modified Levenberg-Marquardt Algorithm J. Magn. Reson., Ser. A 1996, 120, 155-189
63. Smith, C. A.; Calabro, V.; Frankel, A. D. An RNA-Binding Chameleon Mol. Cell 2000, 6, 1067-1076
64. Calnan, B. J.; Biancalana, S.; Hudson, D.; Frankel, A. D. Analysis of Arginine-Rich Peptides from the HIV TAT Protein Reveals Unusual Features of RNA Protein Recognition Genes Dev. 1991, 5, 201-210